{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T21:40:26Z","timestamp":1793310026217,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,31]],"date-time":"2019-10-31T00:00:00Z","timestamp":1572480000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009572","name":"Health and Family Planning Commission of Gansu","doi-asserted-by":"publisher","award":["KJXW2018076"],"award-info":[{"award-number":["KJXW2018076"]}],"id":[{"id":"10.13039\/501100009572","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010881","name":"Suzhou Municipal Science and Technology Bureau","doi-asserted-by":"publisher","award":["SYS2018004"],"award-info":[{"award-number":["SYS2018004"]}],"id":[{"id":"10.13039\/501100010881","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010881","name":"Suzhou Municipal Science and Technology Bureau","doi-asserted-by":"publisher","award":["SYS2018005"],"award-info":[{"award-number":["SYS2018005"]}],"id":[{"id":"10.13039\/501100010881","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.biopha.2019.109606","type":"journal-article","created":{"date-parts":[[2019,11,25]],"date-time":"2019-11-25T07:37:37Z","timestamp":1574667457000},"page":"109606","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"special_numbering":"C","title":["Prodrug of epigallocatechin-3-gallate alleviates choroidal neovascularization via down-regulating HIF-1\u03b1\/VEGF\/VEGFR2 pathway and M1 type macrophage\/microglia polarization"],"prefix":"10.1016","volume":"121","author":[{"given":"Jiaowen","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laiqing","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingliang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghui","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingxia","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manhui","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.biopha.2019.109606_bib0005","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ophtha.2018.08.035","article-title":"G. comparison of age-related macular degeneration treatments trials research, macular morphology and visual acuity in year five of the comparison of age-related macular degeneration treatments trials","volume":"126","author":"Jaffe","year":"2019","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.biopha.2019.109606_bib0010","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.ophtha.2012.10.036","article-title":"Initiative for Macular Research Classification, Clinical classification of age-related macular degeneration","volume":"120","author":"Ferris","year":"2013","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.biopha.2019.109606_bib0015","doi-asserted-by":"crossref","first-page":"470","DOI":"10.4103\/jovr.jovr_67_18","article-title":"Negative regulators of angiogenesis, ocular vascular homeostasis, and pathogenesis and treatment of exudative AMD","volume":"13","author":"Farnoodian","year":"2018","journal-title":"J. Ophthalmic Vis. Res."},{"issue":"4","key":"10.1016\/j.biopha.2019.109606_bib0020","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1444-0938.2007.00152.x","article-title":"Age-related maculopathy in the light of ischaemia","volume":"90","author":"Feigl","year":"2007","journal-title":"Clin. Exp. Optom."},{"issue":"10","key":"10.1016\/j.biopha.2019.109606_bib0025","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1007\/s00417-009-1133-3","article-title":"Expression of hypoxia-inducible factor-1alpha and -2alpha in human choroidal neovascular membranes","volume":"247","author":"Sheridan","year":"2009","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"issue":"1","key":"10.1016\/j.biopha.2019.109606_bib0030","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/eye.2013.240","article-title":"Ritonavir inhibits HIF-1alpha-mediated VEGF expression in retinal pigment epithelial cells in vitro","volume":"28","author":"Vadlapatla","year":"2014","journal-title":"Eye (Lond.)"},{"issue":"1","key":"10.1016\/j.biopha.2019.109606_bib0035","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0002-9440(10)64525-7","article-title":"Overexpression of vascular endothelial growth factor (VEGF) in the retinal pigment epithelium leads to the development of choroidal neovascularization","volume":"157","author":"Spilsbury","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.biopha.2019.109606_bib0040","first-page":"210","article-title":"Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse model","volume":"9","author":"Reich","year":"2003","journal-title":"Mol. Vis."},{"issue":"4","key":"10.1016\/j.biopha.2019.109606_bib0045","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/j.ajpath.2013.12.023","article-title":"VEGFA activates erythropoietin receptor and enhances VEGFR2-mediated pathological angiogenesis","volume":"184","author":"Yang","year":"2014","journal-title":"Am. J. Pathol."},{"issue":"40","key":"10.1016\/j.biopha.2019.109606_bib0050","doi-asserted-by":"crossref","first-page":"10737","DOI":"10.1073\/pnas.1706394114","article-title":"Critical role of caveolin-1 in ocular neovascularization and multitargeted antiangiogenic effects of cavtratin via JNK","volume":"114","author":"Jiang","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.biopha.2019.109606_bib0055","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.immuni.2014.06.008","article-title":"Macrophage activation and polarization: nomenclature and experimental guidelines","volume":"41","author":"Murray","year":"2014","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.biopha.2019.109606_bib0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00011-015-0874-1","article-title":"Macrophage polarization: the link between inflammation and related diseases","volume":"65","author":"Bashir","year":"2016","journal-title":"Inflamm. Res."},{"issue":"9\u201310","key":"10.1016\/j.biopha.2019.109606_bib0065","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.imbio.2010.05.025","article-title":"IL-10 regulation of macrophage VEGF production is dependent on macrophage polarisation and hypoxia","volume":"215","author":"Wu","year":"2010","journal-title":"Immunobiology"},{"key":"10.1016\/j.biopha.2019.109606_bib0070","doi-asserted-by":"crossref","first-page":"655","DOI":"10.3389\/fpls.2015.00655","article-title":"Plant-derived immunomodulators: an insight on their preclinical evaluation and clinical trials","volume":"6","author":"Jantan","year":"2015","journal-title":"Front. Plant Sci."},{"key":"10.1016\/j.biopha.2019.109606_bib0075","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.canlet.2017.09.054","article-title":"A prodrug of green tea polyphenol (-)-epigallocatechin-3-gallate (Pro-EGCG) serves as a novel angiogenesis inhibitor in endometrial cancer","volume":"412","author":"Wang","year":"2018","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.biopha.2019.109606_bib0080","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s10456-012-9299-4","article-title":"Prodrug of green tea epigallocatechin-3-gallate (Pro-EGCG) as a potent anti-angiogenesis agent for endometriosis in mice","volume":"16","author":"Wang","year":"2013","journal-title":"Angiogenesis"},{"issue":"7","key":"10.1016\/j.biopha.2019.109606_bib0085","first-page":"643","article-title":"Perspectives on the recent developments with green tea polyphenols in drug discovery","volume":"13","author":"Li","year":"2018","journal-title":"Expert Opin. Drug Discov."},{"issue":"1","key":"10.1016\/j.biopha.2019.109606_bib0090","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.canlet.2009.11.006","article-title":"Antitumor activity of novel fluoro-substituted (-)-epigallocatechin-3-gallate analogs","volume":"292","author":"Yang","year":"2010","journal-title":"Cancer Lett."},{"issue":"21","key":"10.1016\/j.biopha.2019.109606_bib0095","doi-asserted-by":"crossref","first-page":"5587","DOI":"10.1016\/j.bmc.2004.08.002","article-title":"A potential prodrug for a green tea polyphenol proteasome inhibitor: evaluation of the peracetate ester of (-)-epigallocatechin gallate [(-)-EGCG]","volume":"12","author":"Lam","year":"2004","journal-title":"Bioorg. Med. Chem."},{"issue":"6","key":"10.1016\/j.biopha.2019.109606_bib0100","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1167\/iovs.07-1508","article-title":"Increased choroidal neovascularization following laser induction in mice lacking lysyl oxidase-like 1","volume":"49","author":"Yu","year":"2008","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2019.109606_bib0105","first-page":"435","article-title":"EGCG decreases the expression of HIF-1alpha and VEGF and cell growth in MCF-7 breast cancer cells","volume":"19","author":"Luo","year":"2014","journal-title":"J. BUON"},{"issue":"3","key":"10.1016\/j.biopha.2019.109606_bib0110","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s00280-012-2063-z","article-title":"(-)-Epigallocatechin-3-gallate inhibits human papillomavirus (HPV)-16 oncoprotein-induced angiogenesis in non-small cell lung cancer cells by targeting HIF-1alpha","volume":"71","author":"He","year":"2013","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"6","key":"10.1016\/j.biopha.2019.109606_bib0115","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","article-title":"mTOR signaling in growth, metabolism, and disease","volume":"168","author":"Saxton","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2019.109606_bib0120","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/978-1-4614-3209-8_101","article-title":"Targeting the PI3K\/Akt\/mTOR pathway in ocular neovascularization","volume":"801","author":"Sasore","year":"2014","journal-title":"Adv. Exp. Med. Biol."},{"issue":"43","key":"10.1016\/j.biopha.2019.109606_bib0125","doi-asserted-by":"crossref","first-page":"29739","DOI":"10.1074\/jbc.M114.584821","article-title":"PDK4 protein promotes tumorigenesis through activation of cAMP-response element-binding protein (CREB)-Ras homolog enriched in brain (RHEB)-mTORC1 signaling cascade","volume":"289","author":"Liu","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.biopha.2019.109606_bib0130","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/WNR.0000000000001149","article-title":"Effects and mechanism of epigallocatechin-3-gallate on apoptosis and mTOR\/AKT\/GSK-3beta pathway in substantia nigra neurons in Parkinson rats","volume":"30","author":"Zhou","year":"2019","journal-title":"Neuroreport"},{"issue":"2","key":"10.1016\/j.biopha.2019.109606_bib0135","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s10522-018-9785-1","article-title":"Epigallocatechin gallate suppresses premature senescence of preadipocytes by inhibition of PI3K\/Akt\/mTOR pathway and induces senescent cell death by regulation of Bax\/Bcl-2 pathway","volume":"20","author":"Kumar","year":"2019","journal-title":"Biogerontology"},{"key":"10.1016\/j.biopha.2019.109606_bib0140","first-page":"647","article-title":"Activator protein-1 contributes to the NaCl-induced expression of VEGF and PlGF in RPE cells","volume":"24","author":"Kleiner","year":"2018","journal-title":"Mol. Vis."},{"key":"10.1016\/j.biopha.2019.109606_bib0145","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.cyto.2018.07.011","article-title":"IL-27 regulates HIF-1alpha-mediated VEGFA response in macrophages of diabetic retinopathy patients and healthy individuals","volume":"113","author":"Zhang","year":"2019","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/j.biopha.2019.109606_bib0150","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/09273948.2016.1277247","article-title":"Roles of IL-6 in ocular inflammation: a review","volume":"26","author":"Ghasemi","year":"2018","journal-title":"Ocul. Immunol. Inflamm."},{"issue":"6","key":"10.1016\/j.biopha.2019.109606_bib0155","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1001\/archopht.123.6.774","article-title":"Progression of age-related macular degeneration: prospective assessment of C-reactive protein, interleukin 6, and other cardiovascular biomarkers","volume":"123","author":"Seddon","year":"2005","journal-title":"Arch. Ophthalmol."},{"issue":"6","key":"10.1016\/j.biopha.2019.109606_bib0160","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.2353\/ajpath.2007.061018","article-title":"Interleukin-6 receptor-mediated activation of signal transducer and activator of transcription-3 (STAT3) promotes choroidal neovascularization","volume":"170","author":"Izumi-Nagai","year":"2007","journal-title":"Am. J. Pathol."},{"issue":"9","key":"10.1016\/j.biopha.2019.109606_bib0165","first-page":"1891","article-title":"The potential angiogenic role of macrophages in the formation of choroidal neovascular membranes","volume":"40","author":"Oh","year":"1999","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2019.109606_bib0170","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0002-9440(10)64869-9","article-title":"Retinal vascular endothelial growth factor induces intercellular adhesion molecule-1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal leukocyte adhesion in vivo","volume":"160","author":"Joussen","year":"2002","journal-title":"Am. J. Pathol."},{"issue":"2","key":"10.1016\/j.biopha.2019.109606_bib0175","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3934\/molsci.2016.2.196","article-title":"Oxidative stress, innate immunity, and age-related macular degeneration","volume":"3","author":"Shaw","year":"2016","journal-title":"AIMS Mol. Sci."},{"issue":"6","key":"10.1016\/j.biopha.2019.109606_bib0180","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1111\/acel.12133","article-title":"The phytochemical, EGCG, extends lifespan by reducing liver and kidney function damage and improving age-associated inflammation and oxidative stress in healthy rats","volume":"12","author":"Niu","year":"2013","journal-title":"Aging Cell"},{"issue":"11","key":"10.1016\/j.biopha.2019.109606_bib0185","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.jnutbio.2015.07.001","article-title":"Effects of EGCG content in green tea extract on pharmacokinetics, oxidative status and expression of inflammatory and apoptotic genes in the rat ocular tissues","volume":"26","author":"Chu","year":"2015","journal-title":"J. Nutr. Biochem."},{"issue":"3","key":"10.1016\/j.biopha.2019.109606_bib0190","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1039\/C7FO01554B","article-title":"EGCG evokes Nrf2 nuclear translocation and dampens PTP1B expression to ameliorate metabolic misalignment under insulin resistance condition","volume":"9","author":"Mi","year":"2018","journal-title":"Food Funct."},{"key":"10.1016\/j.biopha.2019.109606_bib0195","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/8476164","article-title":"Molecular mechanisms underlying age-related ocular diseases","volume":"2018","author":"Amadio","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"9","key":"10.1016\/j.biopha.2019.109606_bib0200","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1038\/labinvest.2011.101","article-title":"NSAIDs inhibit neovascularization of choroid through HO-1-dependent pathway","volume":"91","author":"Yoshinaga","year":"2011","journal-title":"Lab. Invest."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333221935228X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333221935228X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T12:10:55Z","timestamp":1778242255000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075333221935228X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":40,"alternative-id":["S075333221935228X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2019.109606","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prodrug of epigallocatechin-3-gallate alleviates choroidal neovascularization via down-regulating HIF-1\u03b1\/VEGF\/VEGFR2 pathway and M1 type macrophage\/microglia polarization","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2019.109606","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"109606"}}